Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview

Lancet

Volumn 355, Issue 9206, 2000, Pages 773-778

  Capes, Sarah E ^a   Hunt, Dereck ^a   Malmberg, Klas ^b   Gerstein, Hertzel C ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ACUTE HEART INFARCTION; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STRESS;

EID: 0034603545     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)08415-9     Document Type: Article

References (46)

1. Cruikshank N. Coronary thrombosis and myocardial infarction, with glycosuria. BMJ 1931; 1: 618-19.
2. Sewdarsen M, Jialal I, Vythilingum S, Govender G, Rajput MC. Stress hyperglycaemia is a predictor of abnormal glucose tolerance in Indian patients with acute myocardial infarction. Diabetes Res 1987; 6: 47-49.
3. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 1986; 293: 917-22.
4. Yudkin JS, Oswald GA. Hyperglycaemia, diabetes and myocardial infarction. Diabetes Med 1987; 4: 13-18.
5. Malmberg K, Ryden L, Efendic S, et al, on behalf of the DIGAMI Study Group. A randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
6. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrythmias. Lancet 1994; 343: 155-58.
7. McKibbon KA, Walder-Dilks C, Haynes RB, Wilczynski N. Beyond ACP Journal Club: how to harness MEDLINE for prognosis problem. ACP J Club 1995 123: A12-14.
8. Lakhdar A, Stromberg P, McAlpine SG. Prognostic importance of hyperglycaemia induced by stress after myocardial infarction. BMJ 1984; 288: 288.
9. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycemia and undiagnosed diabetes mellitus in patients with acute myocardial infarction. Lancet 1984; 1: 1264-67.
10. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
11. Fava S, Aquilina O, Azzopardi J, Agius Muscat H, Fenech FF. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabetes Med 1996; 13: 80-83.
12. Modan B, Schor S, Shani M. Acute myocardial infarction: prognostic value of white blood cell count and blood glucose level. JAMA 1975; 233: 266-67.
13. Jones DB, Scaretto L, Carter R, Mann JI. Glucose, insulin and platelet fatty acids following myocardial infarction: an association with infarct size. DiabetesMetabol 1987; 13: 463-66.
14. Datey KK, Nanda NC. Hyperglycemia after acute myocardial infarction: its relation to diabetes mellitus. N Engl J Med 1967; 276: 262-65.
15. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res 1997; 34: 248-53.
16. Soler NG, Bennett MA, Pentecost BL, Fitzgerald MG, Malins JM. Myocardial infarction in diabetics. QJM 1975; 44: 125-32.
17. Lynch M, Gammage MD, Lamb P, Nattrass M, Pentecost BL. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabetes Med 1994; 11: 162-65.
18. Yudkin JS, Oswald GA. Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 1988; 11: 351-58.
19. Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985; 8: 230-34.
20. Bannerjee AK. Blood sugar and prognosis of acute myocardial infarction in the elderly. Br J Clin Pract 1986; 40: 516-17.
21. Ravid M, Berkowicz M, Sohar E. Hyperglycaemia during acute myocardial infarction: a six-year follow-up study. JAMA 1975; 233: 807-09.
22. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycaemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64: 885-88.
23. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 1981; 246: 1690-93.
24. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991; 14: 758-60.
25. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S and the SPRINT Study Group. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors and outcome. Am J Med 1993; 94: 265-73.
26. Sewdarsen M, Vythilingum S, Jialal I, Becker PJ. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. QJM 1989; 71: 461-66.
27. Lewandowicz J, Komorovski JM, Gozlinski H. Metabolic disorders in myocardial infarction: changes of blood serum zinc, growth hormone, insulin and glucose concentration in patients with acute myocardial infarction. Cor Vasa 1979; 21: 305-16.
28. Gwilt DJ, Petri M, Lamb P, Nattrass M, Pente cost BL. Effects of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J 1984; 51: 626-30.
29. Allison SP, Tomlin PJ, Chamberlain MJ. Some effects of anaesthesia and surgery on carbohydrate and fat metabolism. Br J Anaesth 1969; 41: 588-92.
30. Clarke RSJ, Johnston H, Sheridan B. The influence of anaesthesis and surgery on plasma cortisol, insulin and free fatty acids. Br J Anaesth 1970; 42: 295-99.
31. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 1971; 50: 1386-89.
32. Malmberg K, Herlitz J, Hjalmarson Å, Rydén L. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction: retrospective data from two large studies. Eur Heart J 1989; 10: 423-28.
33. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991; 68: 466-81.
34. Fath-ordoubadi F, Beatt KJ. Glucose-insluin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997; 96: 1152-56.
35. Malmberg K for the DIGAMI Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 1512-15.
36. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Circulation 1999; 99: 2626-32.
37. Holubarsch C, Ruf T, Goldstein DJ, et al. Existence of the Frank-Starling mechanism in the failing human heart: investigations on the organ, tissue, and sarcomere levels. Circulation 1996; 94: 683-89.
38. Marcus JT, Gotte MJ, Van Rossum AC, eta l. Myocardial function in infarcted and remote regions early after infarction in man: assessment by magnetic resonance tagging and strain analysis. Magn Reson Med 1997; 38: 803-10.
39. Tansey MJB, Opie LH. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol 1986; 2: 326-31.
40. Thomassen AR, Mortensen PT, Nielsen TT, Falstie-Jensen N, Thygesen K, Henningsen P. Altered plasma concentrations of glutamate, alanine and citrate in the early phase of acute myocardial infarction in man. Eur Heart J 1986; 7: 773-78.
41. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12·4 years. Diabetes Care 1999; 22: 233-40.
42. Davi G, Catalano I, Averna M, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl JMed 1990; 322: 1769-74.
43. Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS. Insulin therapy in type 2 diabetic patients suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabetes Med 1993; 10: 27-32.
44. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296-306.
45. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403-18.
46. Pfeffer MA, Moye LA, Braunwald E, et al, for the SAVE Investigators. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA 1991; 266: 528-32.